Skip to main content

Table 3 This table shows the serum hormonal characteristics of the cases and controls.

From: Evaluation of early atherosclerotic findings in women with polycystic ovary syndrome

Variable

Groups

Number

Mean ± SD

P Value

FSH (mIu/ml)

Controls

45

5.57 ± 1.88

0.01

 

Cases

46

7.33 ± 4.25

 

LH (mIu/ml)

Controls

45

5.46 ± 4.72

0.24

 

Cases

46

26.51 ± 14.63

 

PRL (ng/ml)

Controls

45

13.61 ± 5.39

0.001

 

Cases

46

21.15 ± 19.11

 

Testosterone

Controls

45

0.55 ± 0.87

0.001

 

Cases

46

1.58 ± 1.21

 

DHEAS (g/dl μ)

Controls

45

187.22 ± 105.61

0.001

 

Cases

46

284.48 ± 111.18

 

17(OH) Progesterone (ng/dl)

Controls

45

1.25 ± 0.76

0.23

 

Cases

46

1.69 ± 2.35

 

Insulin (mIu/ml)

Controls

45

4.34 ± 1.90

0.001

 

Cases

46

12.62 ± 8.13